China India covid-19 testing vaccine China India

Sinopharm’s third covid vaccine approved for clinical trial in China

Reading now: 249
www.livemint.com

China has approved the third Covid-19 vaccine from Sinopharm Group Co. to start clinical trials, the company said.The green light to begin testing comes after two inactivated vaccines from Sinopharm were approved and widely used both at home and in developing countries.The latest one is a recombinant vaccine that includes parts of the coronavirus’s spike protein to stimulate immune response, according to a release posted on the company’s official WeChat account on Saturday.Click here to read the Mint ePaperMint is now on Telegram.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA